Dominik Ruettinger

Dominik Ruettinger is an experienced individual who has held various leadership positions in the pharmaceutical industry. As the SVP, Global Head Research and Early Development Oncology at Bayer since October 2021, Dominik also serves as an Associate Professor at Ludwig-Maximilians Universität München since December 1996. Prior to their current roles, Dominik worked at companies such as Roche and Micromet AG, where Dominik held senior leadership positions in oncology research and development. With an MD, PhD from Ludwig-Maximilians-Universität München and further education from Oregon Health & Science University and Stanford University Graduate School of Business, Dominik brings a wealth of knowledge and expertise to their roles.